Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and ...

"At present, no clear causal relationship has been established between these rare events and the Janssen COVID-19 vaccine." ...

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...

An overwhelming majority of Dutch people have no regrets about being vaccinated against coronavirus during the pandemic, ...

The COVID-19 vaccine has prompted more than 10 times as many reports of adverse symptoms than the measles vaccine.

A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

Cornell University researchers used a new technology to design a vaccine that they say provides full protection against both ...

The number of people in the Netherlands declared partially or fully unfit for work due to long Covid has risen sharply in ...

The current COVID-19 vaccine is 33% effective at preventing emergency department or urgent care visits among adults of all ages. It also is 45% to 46% effective at preventing hospitalizations in older ...

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .